Psychotomimetic effects of drugs--a common pathway to schizophrenia?
Gerber
David J
DJ
Picower Center, Massachusetts Institute of Technology, Boston, USA.
Tonegawa
Susumu
S
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D002491:Central Nervous System Agents / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D051379:Mice; D023421:Models, Animal; D009419:Nerve Tissue Proteins; D010622:Phencyclidine / Q000494:pharmacology; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000209:etiology*; D015398:Signal Transduction
D002491:Central Nervous System Agents; D051937:Dopamine and cAMP-Regulated Phosphoprotein 32; D009419:Nerve Tissue Proteins; D010750:Phosphoproteins; D011954:Receptors, Dopamine; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D010622:Phencyclidine